Post-Operative Myocardial Incident & Atrial Fibrillation
Launched by UNIVERSITY HOSPITAL, LILLE · Dec 15, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Post-Operative Myocardial Incident & Atrial Fibrillation," is investigating how certain factors in patients’ bodies before heart surgery can affect their recovery and risk of serious heart problems afterward. Specifically, the study looks at how white blood cells, fat, and heart muscle characteristics may predict major heart events after procedures like coronary artery bypass surgery or valve replacement. The researchers hope to better understand these connections to improve patient outcomes after surgery.
To be eligible for this trial, participants must be between the ages of 65 and 74 and scheduled for cardiac surgery or a specific heart valve procedure. Unfortunately, pregnant women, those needing urgent surgery, or individuals who cannot provide consent cannot participate. If you join the study, you can expect to undergo routine medical evaluations as part of your treatment, and your health will be monitored closely to help gather important data for the research. This trial aims to enhance the care and recovery process for patients undergoing significant heart interventions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients scheduled for cardiac surgery (coronary artery bypass graft surgery and/or valvular surgery) or transcatheter valve implantation
- Exclusion Criteria:
- • pregnant woman
- • urgent surgery or intervention
- • not able to consent to the protocol
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, , France
Patients applied
Trial Officials
David Montaigne, Prof.
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials